In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …

Purpose: Acute myeloid leukemia (AML) with t (7; 11)(p15; p15), which results in fusion of
NUP98 and HOXA9 genes, is rarely seen, especially in Western countries. Till now only few …

Acute myeloid leukemia (AML) with t (3; 5)(q25; q34), belonging to AML with myelodys-
plasia related changes according to WHO classification in 2008, is a subtype of AML that is …

Pediatric acute myeloid leukemia (AML) is a rare, heterogeneous disease, characterized by
recurrent cytogenetic and molecular aberrations. 1, 2 Genetic aberrations are the most …

Acute myeloid leukaemia (AML), typically a disease of elderly adults, affects 8 children per
million each year, with the highest paediatric incidence in infants aged 0–2 of 18 per million …

Introduction Translocations involving the KMT2A gene (also known as MLL) are frequently
diagnosed in pediatric acute leukemia cases with either lymphoblastic or myeloid origin …

Acute myeloid leukemia (AML) with the t (7; 12)(q36; p13) translocation occurs only in very
young children and has a poor clinical outcome. The expected oncofusion between …

We report the nonrandom occurrence and frequency of the t (1; 22)(p13; q13) in acute
myeloid leukemia (AML) and its close association with the French-American-British M7 …

Acute myeloid leukemia with t (6; 9)(p22; q34) is listed as a distinct entity in the 2008 World
Health Organization classification, but little is known about the clinical implications of t (6; 9) …